FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q1 2020

Top Holdings102 positions

Checking export access…
Activity:
AGNAGNDelisted

ALLERGAN PLC

9.3M$1.6B14.1%——
4 qtrssince 2019-Q2
Increased
72
SPYSPY
PUT

STATE STR SPDR S&P 500 ETF T

2.6M$721.5M6.2%———
Decreased
—

FIDELITY NATL INFORMATION SV

4.6M$562.1M4.8%$102.06+9.08%
6 qtrssince 2018-Q4
Increased
74

CENTENE CORP DEL

7.3M$430.7M3.7%$59.410.00%
1 qtr
New
86

IQVIA HLDGS INC

3.7M$403.4M3.5%$117.56-3.89%
6 qtrssince 2018-Q4
Increased
92

THERMO FISHER SCIENTIFIC INC

1.2M$352.6M3.0%$306.34-9.03%
2 qtrssince 2019-Q4
Increased
77

ALPHABET INC

295,173$343.2M2.9%$56.30+2.30%
6 qtrssince 2018-Q4
Increased
57

CHARTER COMMUNICATIONS INC

723,328$315.6M2.7%$295.09+52.76%
6 qtrssince 2018-Q4
Increased
56
1.7M$307.4M2.6%——
3 qtrssince 2019-Q3
Decreased
0

ABBVIE INC

4M$304.8M2.6%$61.56-4.45%
3 qtrssince 2019-Q3
Increased
76

WABTEC

6.3M$304.3M2.6%$63.37-26.85%
6 qtrssince 2018-Q4
Increased
65
4.9M$295.5M2.5%——
6 qtrssince 2018-Q4
Increased
81

MICROSOFT CORP

1.8M$287.6M2.5%$116.22+28.38%
6 qtrssince 2018-Q4
Decreased
0

VISA INC

1.8M$284.1M2.4%$138.18+11.26%
6 qtrssince 2018-Q4
Increased
61

ELEVANCE HEALTH INC FORMERLY

1.3M$283.8M2.4%$246.79-13.54%
6 qtrssince 2018-Q4
Unchanged
0

GENERAL DYNAMICS CORP

2.1M$275.7M2.4%$125.51-7.38%
6 qtrssince 2018-Q4
Increased
85

SHERWIN WILLIAMS CO

509,130$234M2.0%$138.25+4.57%
5 qtrssince 2019-Q1
Increased
69

SALESFORCE INC

1.6M$232.5M2.0%$159.59-11.47%
2 qtrssince 2019-Q4
Decreased
0

THE CIGNA GROUP

1.3M$221.5M1.9%$175.20-6.92%
6 qtrssince 2018-Q4
Decreased
0
BABABABA
ADR

ALIBABA GROUP HLDG LTD

1.1M$218.5M1.9%$152.89+18.81%
6 qtrssince 2018-Q4
Decreased
0
$11.7B
AUM
102
Positions
Q1 2020
Filing
HI score · 1.0/5
Quarterly 13F Value Change
+6%Q1'19$12.1B+18%Q2'19$14.3B-15%Q3'19$12.2B+6%Q4'19$13B-16%Q1'20$10.9B
Activity profile
$ moved · Q1'20
New12%Increased22%Decreased25%Exited41%
Composition
Equity vs derivatives
Equity94%Puts6%Calls0%
Holding period
Avg 3.0 quarters
<1Q19%1-4Q29%1-2Y52%2Y+0%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $11.7B across 102 positions as of Q1 2020. Top holdings: AGN (14.1%), SPY puts (6.2%), FIS (4.8%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.

Q1 2020 Summary

Active quarter - 20 new positions, 32 exits, 39 increased. Top move: IQV (INCREASED, conviction 92). Portfolio: $11.7B across 102 positions.

Top holdings by portfolio weight

Total AUM$11B
AGN14.14%
FIS4.83%
CNC3.70%
IQV3.46%
TMO3.03%
GOOG2.95%
CHTR2.71%
HNIB2.64%
ABBV2.62%
WAB2.61%
Other2.54%

Portfolio allocation by GICS sector

Sectors9
Unknown32.07%
Healthcare32.03%
Technology11.80%
Communication Services7.97%
Industrials5.95%
Financial Services4.14%
Basic Materials2.22%
Consumer Cyclical2.07%
Real Estate1.76%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown, Healthcare, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L46
Conviction44
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+9M shares+$755.7M
7Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q4 2024 → Q2 2026+7.8M shares+$277M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 → Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used